Holen Sie sich die Stockscreener-App
2.13
8.40%
0.165
Vorhandelsmarkt:
2.13
Schlusskurs vom Vortag:
$1.965
Offen:
$2.06
24-Stunden-Volumen:
433.11K
Relative Volume:
1.56
Marktkapitalisierung:
$56.13M
Einnahmen:
$18.94M
Nettoeinkommen (Verlust:
$-2.71M
KGV:
-15.21
EPS:
-0.14
Netto-Cashflow:
$-4.92M
1W Leistung:
+9.23%
1M Leistung:
+16.39%
6M Leistung:
+63.85%
1J Leistung:
+38.31%
1-Tages-Spanne:
$2.06
$2.21
1-Wochen-Bereich:
$1.81
$2.21
52-Wochen-Spanne:
$1.18
$2.6499
Icad Inc Stock (ICAD) Company Profile
Firmenname
Icad Inc
Sektor
Branche
Telefon
603-882-5200
Adresse
98 SPIT BROOK ROAD, SUITE 100, NASHUA, NH
Vergleichen Sie ICAD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ICAD
Icad Inc
|
2.13 | 56.13M | 18.94M | -2.71M | -4.92M | -0.14 |
|
ABT
Abbott Laboratories
|
116.79 | 201.01B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
395.85 | 150.90B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
100.91 | 148.72B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.38 | 113.33B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.97 | 41.27B | 6.60B | 4.16B | 490.10M | 6.93 |
Icad Inc Stock (ICAD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-01-18 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-04-22 | Eingeleitet | Guggenheim | Buy |
| 2021-03-23 | Eingeleitet | BTIG Research | Buy |
| 2021-02-26 | Eingeleitet | Oppenheimer | Outperform |
| 2021-01-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-12-03 | Eingeleitet | B. Riley Securities | Buy |
| 2020-02-05 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-01-09 | Eingeleitet | Lake Street | Buy |
| 2008-12-09 | Bestätigt | Canaccord Adams | Buy |
| 2008-08-01 | Bestätigt | MDB Capital Group | Buy |
| 2008-05-14 | Bestätigt | Canaccord Adams | Buy |
| 2008-02-14 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
| 2007-01-24 | Bestätigt | Dawson James | Speculative Buy |
Alle ansehen
Icad Inc Aktie (ICAD) Neueste Nachrichten
Zacks Market Edge Highlights: FiscalNote, and iCAD - Yahoo Finance
iCAD, Inc. (NASDAQ:ICAD) Sees Significant Decline in Short Interest - MarketBeat
Discover the AI Stocks Under $5 That Investors Are Talking About - Kuhinje EWE Daily
2 AI Stocks Under $5 - Yahoo Finance
Strategic Acquisitions by Hologic and iCAD Shape Future of CAD Market - openPR
iCAD (NASDAQ:ICAD) Shares Pass Above 200-Day Moving AverageShould You Sell? - MarketBeat
iCAD (NASDAQ:ICAD) Share Price Crosses Above 200 Day Moving AverageWhat's Next? - MarketBeat
FDA Clears iCAD’s ProFound Detection Version 4.0 - MPO-mag
iCAD (NASDAQ:ICAD) Shares Pass Above Two Hundred Day Moving Average – Should You Sell? - Defense World
Head-To-Head Comparison: iCAD (NASDAQ:ICAD) & Todos Medical (OTCMKTS:TOMDF) - Defense World
iCAD (NASDAQ:ICAD) Stock Price Passes Above Two Hundred Day Moving Average – Should You Sell? - Defense World
iCAD (NASDAQ:ICAD) Stock Passes Above 200 Day Moving AverageTime to Sell? - MarketBeat
SABCS 2024: New Research Assesses iCAD’s Image Based - GlobeNewswire
iCAD's AI Breast Cancer Detection Breakthrough: New Research Shows Superior Risk Assessment Performance - StockTitan
CORRECTION – iCAD Advances Fight Against Breast Cancer with - GlobeNewswire
iCAD's New AI Breakthrough Boosts Breast Cancer Detection by 23%, Partners with Cascaid Health - StockTitan
US Penny Stocks To Watch In December 2024 - Simply Wall St
Breast Cancer Brachytherapy Market Growth in Future Scope - openPR
Global Computer-Aided Detection (CAD) Software Market Size, - openPR
iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership with Cascaid Health at RSNA 2024 - The Manila Times
iCAD Advances Fight Against Breast Cancer with FDA-cleared, - GlobeNewswire
iCAD's New AI Cancer Detection System Boosts Accuracy by 22%, Partners with Cascaid Health | ICAD Stock News - StockTitan
U.S. Computer-Aided Detection (CAD) Market Future Business - openPR
Computer Aided Detection (CAD) Market: Expected Positive - openPR
Need To Know: Analysts Just Made A Substantial Cut To Their iCAD, Inc. (NASDAQ:ICAD) Estimates - Yahoo Finance
iCAD Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
iCAD, Inc. (NASDAQ:ICAD) Q3 2024 Earnings Call Transcript - Insider Monkey
iCAD (NASDAQ:ICAD) Rating Lowered to “Sell” at StockNews.com - Defense World
ICAD, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Earnings call: iCAD reports steady growth with SaaS transition By Investing.com - Investing.com Canada
Q3 2024 ICAD Inc Earnings Call - Cbainfo
iCad Inc. (ICAD) Quarterly 10-Q Report - Quartzy
Icad: Q3 Earnings Snapshot - New Haven Register
icad Inc (ICAD) Q3 2024 Earnings Call Highlights: Revenue Growth Amidst Strategic Shifts - GuruFocus.com
iCAD, Inc. Reports Growth in ARR and Revenue - TipRanks
iCAD reports Q3 adjusted EPS (7c), consensus (8c) - TipRanks
iCAD Inc Reports Q3 2024 Revenue of $4.2 Million, EPS Loss of $0 - GuruFocus.com
iCAD Reports Financial Results for Third Quarter Ended September 30, 2024 - GlobeNewswire
iCAD Q3 Revenue Grows 4%, Secures FDA Clearance for Enhanced Cancer Detection Tech | ICAD Stock News - StockTitan
iCAD AI breast cancer detection tool gains FDA approval By Investing.com - Investing.com Australia
FDA clears AI-powered breast cancer detection tech from iCad - Mass Device
iCAD announces ProFound Detection for DBT received clearance from FDA - TipRanks
iCAD's ProFound Detection Version 4.0 Gets FDA Clearance - Imaging Technology News
iCAD AI breast cancer detection tool gains FDA approval - Investing.com
iCAD's ProFound Detection Version 4.0 Gains FDA Clearance - GlobeNewswire
iCAD's AI Cancer Detection Gets FDA Nod, Shows 60% Better Accuracy in Key Areas | ICAD Stock News - StockTitan
iCAD, Inc. (NASDAQ:ICAD) Looks Just Right With A 47% Price Jump - Simply Wall St
Volpara, DHA Sign Deal to Modernize Mammography Services - Imaging Technology News
iCAD to Attend 15th Annual Craig-Hallum Alpha Select Conference - GlobeNewswire
iCAD to Present at Craig-Hallum Conference: AI Healthcare Leader Meets Institutional Investors | ICAD Stock News - StockTitan
iCAD to Report Third Quarter 2024 Financial Results on November 13, 2024 - GlobeNewswire
Finanzdaten der Icad Inc-Aktie (ICAD)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):